GKGerd Koehler

Gerd Koehler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gerd Koehler has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study

    by Gillian Leigh Garden, Fariba Shojaee-Moradie, Ewan J. Hutchison, Brian Murray Frier, Kenneth M. Shaw, Simon R. Heller, Gerd Koehler, Julia K. Mader, Declan Maher, Graham A. Roberts, et al.

    Background and Aims: A preliminary study compared the use of continuous glucose monitoring (CGM) with the use of self-monitored blood glucose (SMBG) by aircraft pilots with insulin-treated diabetes in the United Kingdom, Ireland, and Austria, certified to fly commercial aircraft within the European Aviation Safety Agency ARA.MED.330 protocol. Methods: SMBG and simultaneous interstitial glucose measurements using CGM (Dexcom G6 ® ) were recorded during pre- and in-flight periods. Results: Eight male pilots (seven with type 1 diabetes and one with type 3c diabetes), median age of 48.5 years and median diabetes duration of 11.5 years, participated. The correlation coefficient ( R ) between 874 contemporaneously recorded SMBG and CGM values was 0.843, P < 0.001. The mean glucose concentration was 8.78 mmol/L (standard deviation [SD] 0.67) using SMBG compared with 8.71 mmol/L (SD 0.85) recorded using CGM. The mean absolute relative difference was 9.39% (SD 3.12). Conclusions: CGM using Dexcom G6 systems is a credible alternative to SMBG for monitoring glucose levels when insulin-treated pilots fly commercial aircraft. The study was registered with Clinical Trials.gov NCT04395378.


  • Open Access

    Assessment of accuracy and glycemic control of FGM and CGM and impact on mental well-being

    by Manuel Gesslbauer, Gerd Koehler, Christian Baumgartner, Jasmina Lozanović Šajić

    The incidence of diabetes is increasing globally. Short and long-term effects of diabetes can negatively affect the lives of a person and their relatives. A good glycaemic control is important. Compared to conventional blood glucose measurement with capillary blood, which is obtained by finger pricking, it is now possible to continuously measure glucose using sensors that are placed in the subcutaneous tissue and remain there for several days to weeks. This means that the "tissue sugar" and not the blood sugar directly is determined. For this reason, it is important to determine the accuracy of these sensors. Furthermore, such systems can influence not only the physical but also the psychological/mental health of people with diabetes and their relatives. Reimbursement of sensors differs in Europe. This overview is based on the Austrian health care system.